<DOC>
	<DOCNO>NCT01258699</DOCNO>
	<brief_summary>This study Comparing Pharmacokinetics BK-C-0701 320mg , 480mg Thiocacid HR Tab 600mg Healthy Adult Male Subjects .</brief_summary>
	<brief_title>A Study Comparing Pharmacokinetics BK-C-0701 320mg , 480mg Thiocacid HR Tab 600mg Healthy Adult Male Subjects</brief_title>
	<detailed_description />
	<criteria>Male 20 45 Weight 50 90kg , 20 % ideal weight . Ideal weight ( kg ) = ( height ( cm ) 100 ) *0.9 Medical history , physical examination , ECG laboratory test suitable study judge investigator . Patient willing use effective method contraception study 1 month use study drug cease . ( Effective method=spermicide condom ) Subject able give write informed consent prior study start comply study requirement . Patient receive drug affect study within 14 day study initiation . Patient receive drugmetbolizing enzyme inducer inhibitor Barbiturates within 1 month study initiation . Subject hypersensitive investigational drug ( Thioctic acid ) . Patient gastrointestinal history affect absorbing investigational drug inhibit normal gastrointestinal motility , gastrointestinal operation gastrointestinal wound . Patient renal , hepatic , bronchopulmonary , cardiovascular , gastrointestinal , metabolic , neurological , psychotic , oncologic , allergic disease , myocardial infarction , cardiac crisis , hepatitis pancreatitis history . ECG abnormal . Patient abused drug . Patient join clinical study within 3 month study initiation . Patient doanted whole blood within 2 month plasma blood within 1 month first medication . HBsAg , HCV Ab HIV Ab positive . Patient suitable study judge investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>